These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 15589693

  • 1. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S, Lopez-Soriano J, Holst D, Gaudel C, Jehl-Pietri C, Fredenrich A, Grimaldi PA.
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [Abstract] [Full Text] [Related]

  • 2. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?
    Grimaldi PA.
    Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729
    [Abstract] [Full Text] [Related]

  • 3. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.
    Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehl-Pietri C, Fredenrich A, Grimaldi PA.
    Biochim Biophys Acta; 2005 May 30; 1740(2):313-7. PubMed ID: 15949697
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
    Kannisto K, Chibalin A, Glinghammar B, Zierath JR, Hamsten A, Ehrenborg E.
    Int J Mol Med; 2006 Jan 30; 17(1):45-52. PubMed ID: 16328010
    [Abstract] [Full Text] [Related]

  • 5. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
    Risérus U, Sprecher D, Johnson T, Olson E, Hirschberg S, Liu A, Fang Z, Hegde P, Richards D, Sarov-Blat L, Strum JC, Basu S, Cheeseman J, Fielding BA, Humphreys SM, Danoff T, Moore NR, Murgatroyd P, O'Rahilly S, Sutton P, Willson T, Hassall D, Frayn KN, Karpe F.
    Diabetes; 2008 Feb 30; 57(2):332-9. PubMed ID: 18024853
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
    Chen W, Wang LL, Liu HY, Long L, Li S.
    Basic Clin Pharmacol Toxicol; 2008 Sep 30; 103(3):240-6. PubMed ID: 18684227
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD, Wagner N.
    Pharmacol Ther; 2010 Mar 30; 125(3):423-35. PubMed ID: 20026355
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome.
    Takahashi S, Tanaka T, Kodama T, Sakai J.
    Pharmacol Res; 2006 Jun 30; 53(6):501-7. PubMed ID: 16713711
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular disease and PPARdelta: targeting the risk factors.
    Muscat GE, Dressel U.
    Curr Opin Investig Drugs; 2005 Sep 30; 6(9):887-94. PubMed ID: 16187688
    [Abstract] [Full Text] [Related]

  • 10. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta.
    Ehrenborg E, Krook A.
    Pharmacol Rev; 2009 Sep 30; 61(3):373-93. PubMed ID: 19805479
    [Abstract] [Full Text] [Related]

  • 11. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G, Torres N, Tovar AR.
    Rev Invest Clin; 2004 Sep 30; 56(3):351-67. PubMed ID: 15612519
    [Abstract] [Full Text] [Related]

  • 12. Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta.
    Sprecher DL.
    Am J Cardiol; 2007 Dec 03; 100(11 A):n20-4. PubMed ID: 18047848
    [Abstract] [Full Text] [Related]

  • 13. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T, Alvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer X, Laguna JC, Vázquez-Carrera M.
    Endocrinology; 2010 Apr 03; 151(4):1560-9. PubMed ID: 20185762
    [Abstract] [Full Text] [Related]

  • 14. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL, Lin JJ, Goldfine ID.
    Curr Diabetes Rev; 2005 Aug 03; 1(3):299-307. PubMed ID: 18220606
    [Abstract] [Full Text] [Related]

  • 15. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
    Jucker BM, Yang D, Casey WM, Olzinski AR, Williams C, Lenhard SC, Legos JJ, Hawk CT, Sarkar SK, Newsholme SJ.
    Am J Physiol Endocrinol Metab; 2007 Nov 03; 293(5):E1256-64. PubMed ID: 17726146
    [Abstract] [Full Text] [Related]

  • 16. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.
    Flachs P, Rossmeisl M, Bryhn M, Kopecky J.
    Clin Sci (Lond); 2009 Jan 03; 116(1):1-16. PubMed ID: 19037880
    [Abstract] [Full Text] [Related]

  • 17. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
    Jeong HW, Lee JW, Kim WS, Choe SS, Shin HJ, Lee GY, Shin D, Lee JH, Choi EB, Lee HK, Yon GH, Cho B, Kim HR, Choi SH, Chung YS, Park SB, Chung H, Ro S, Kim JB.
    Mol Pharmacol; 2010 Nov 03; 78(5):877-85. PubMed ID: 20724462
    [Abstract] [Full Text] [Related]

  • 18. Metabolic Functions of Peroxisome Proliferator-Activated Receptor beta/delta in Skeletal Muscle.
    Gaudel C, Grimaldi PA.
    PPAR Res; 2007 Nov 03; 2007():86394. PubMed ID: 17389772
    [Abstract] [Full Text] [Related]

  • 19. Retinoic acid activation of peroxisome proliferation-activated receptor delta represses obesity and insulin resistance.
    Wolf G.
    Nutr Rev; 2010 Jan 03; 68(1):67-70. PubMed ID: 20042001
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability.
    Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, Grimaldi PA.
    FASEB J; 2003 Dec 03; 17(15):2299-301. PubMed ID: 14525942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.